Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload.
暂无分享,去创建一个
D N Firmin | D J Pennell | D. Pennell | D. Firmin | L. Anderson | N. Bunce | J. M. Walker | J. Porter | N. Bunce | J M Walker | L J Anderson | S Holden | B Davis | E Prescott | C C Charrier | N H Bunce | B Wonke | J Porter | B. Wonke | B. Davis | C. Charrier | E. Prescott | S. Holden | C. Charrier | Nicholas H. Bunce | Lisa J. Anderson | Bernard A. Davis | Emma Prescott | CC Charrier | David N. Firmin | Beatrix Wonke | JM Walker | Dudley J. Pennell | JM Walker | J. Walker
[1] A. Roos,et al. Evaluation of cardiac function with magnetic resonance imaging. , 1994, American heart journal.
[2] V L Morgan,et al. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[3] J. Olynyk,et al. A population-based study of the clinical expression of the hemochromatosis gene. , 1999, The New England journal of medicine.
[4] R. Gottschalk,et al. Non‐invasive quantitation of liver iron‐overload by magnetic resonance imaging , 1990, British journal of haematology.
[5] A. Nienhuis,et al. EVALUATION OF CARDIAC FUNCTION IN PATIENTS WITH THALASSEMIA MAJOR , 1980, Annals of the New York Academy of Sciences.
[6] E R McVeigh,et al. In vivo measurement of T*2 and field inhomogeneity maps in the human heart at 1.5 T , 1998, Magnetic resonance in medicine.
[7] R H Hruban,et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.
[8] Matthew Darlison,et al. Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia Register , 2000, The Lancet.
[9] W. Henry,et al. Echocardiographic abnormalities in patients with transfusion-dependent anemia and secondary myocardial iron deposition. , 1978, The American journal of medicine.
[10] O. Ernst,et al. Hepatic iron overload: diagnosis and quantification with MR imaging. , 1997, AJR. American journal of roentgenology.
[11] J. Porter,et al. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia , 2000 .
[12] D. Vassilopoulos,et al. Apolipoprotein E 4 Allele as a Genetic Risk Factor for Left Ventricular Failure in Homozygous β-Thalassemia , 1998 .
[13] D. Vassilopoulos,et al. Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. , 1998, Blood.
[14] W. Roberts,et al. Iron in the heart. Etiology and clinical significance. , 1971, The American journal of medicine.
[15] J. Villeneuve,et al. Variability in hepatic iron concentration measurement from needle-biopsy specimens. , 1996, Journal of hepatology.
[16] S. Sherlock,et al. Measurement of liver-iron concentration in needle-biopsy specimens. , 1971, Lancet.
[17] J. Gomori,et al. Hepatic iron overload: quantitative MR imaging. , 1991, Radiology.
[18] R M Henkelman,et al. Transverse relaxation rate enhancement caused by magnetic particulates. , 1989, Magnetic resonance imaging.
[19] M. Jessup,et al. Diagnosis and Management of Iron‐induced Heart Disease in Cooley's Anemia , 1998, Annals of the New York Academy of Sciences.
[20] A. Hoffbrand,et al. High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. , 1990, Acta haematologica.
[21] H. Bonkovsky,et al. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. , 1999, Radiology.
[22] M. Bronner,et al. Quantitative study of the variability of hepatic iron concentrations. , 1999, Clinical chemistry.
[23] M. Bock,et al. BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery. , 1999 .
[24] Y Gandon,et al. Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging. , 1994, Radiology.
[25] E. Haacke,et al. Myocardial signal response to dipyridamole and dobutamine: Demonstration of the BOLD effect using a double‐echo gradient‐echo sequence , 1996, Magnetic resonance in medicine.
[26] N. Olivieri,et al. Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. , 1996, The Canadian journal of cardiology.
[27] D. L. Johnston,et al. Assessment of tissue iron overload by nuclear magnetic resonance imaging. , 1989, The American journal of medicine.
[28] P. Toutouzas,et al. Myocarditis in β-Thalassemia Major A Cause of Heart Failure , 1995 .
[29] A. Piga,et al. SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJOR , 1989, The Lancet.
[30] J. H. MacMillan,et al. Survival in medically treated patients with homozygous beta-thalassemia. , 1994, The New England journal of medicine.
[31] D. Tsiapras,et al. Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex. , 1999, Circulation.
[32] D. Stark. Hepatic iron overload: paramagnetic pathology. , 1991, Radiology.
[33] D. Halperin,et al. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. , 1993, Chest.
[34] G. Link,et al. Pathophysiology of Iron Overload a , 1998, Annals of the New York Academy of Sciences.
[35] F. Jensen,et al. Non‐invasive assessment of tissue iron overload in the liver by magnetic resonance imaging , 1994, British journal of haematology.
[36] R. Macdonald,et al. Hemochromatosis and hemosiderosis. Study of 211 autopsied cases. , 1960, Archives of internal medicine.
[37] E. Arbustini,et al. Myocardial iron grading by endomyocardial biopsy. A clinico‐pathologic study on iron overloaded patients , 1989, European journal of haematology.
[38] J. H. MacMillan,et al. Survival in Medically Treated Patients with Homozygous β-Thalassemia , 1994 .